Compare SJM & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SJM | RGC |
|---|---|---|
| Founded | 1897 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 9.8B |
| IPO Year | N/A | 2021 |
| Metric | SJM | RGC |
|---|---|---|
| Price | $100.43 | $46.48 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $115.08 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 797.7K |
| Earning Date | 02-26-2026 | 10-24-2025 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,773,200,000.00 | N/A |
| Revenue This Year | $4.88 | N/A |
| Revenue Next Year | $2.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $93.30 | $0.09 |
| 52 Week High | $121.48 | $83.60 |
| Indicator | SJM | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 70.65 |
| Support Level | $95.09 | $34.00 |
| Resistance Level | $100.19 | $69.00 |
| Average True Range (ATR) | 1.97 | 8.19 |
| MACD | 0.19 | 2.69 |
| Stochastic Oscillator | 94.44 | 56.74 |
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.